PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Centre for Dengue Research, Faculty of Medical Sciences, University of Sri Jayawardenapura, Nugegoda, Sri Lanka.\', \'Allergy, Immunology and Cell Biology Unit, University of Sri Jayewardenepura, Nugegoda, Sri Lanka.\', \'National Institute of Infectious Diseases, Angoda, Sri Lanka.\', \'Colombo Municipality Council, Colombo, Sri Lanka.\', \'National Hospital Kandy, Kandy, Sri Lanka.\', \'MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.\', \'Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, Singapore.\', \'Centre for Dengue Research, Faculty of Medical Sciences, University of Sri Jayawardenapura, Nugegoda, Sri Lanka. gathsaurie.malavige@ndm.ox.ac.uk.\', \'MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK. gathsaurie.malavige@ndm.ox.ac.uk.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1038/s41598-021-81629-2
?:doi
?:hasPublicationType
?:journal
  • Scientific reports
is ?:pmid of
?:pmid
?:pmid
  • 33479465
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.533
?:rankingScore_hIndex
  • 122
?:title
  • SARS-CoV-2 neutralizing antibodies in patients with varying severity of acute COVID-19 illness.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33479465>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33479465>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all